These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2872807

  • 1. Cumulative experience with terazosin administered in combination with diuretics.
    Rudd P.
    Am J Med; 1986 May 23; 80(5B):49-54. PubMed ID: 2872807
    [Abstract] [Full Text] [Related]

  • 2. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG.
    Am J Med; 1986 May 23; 80(5B):55-61. PubMed ID: 2872808
    [Abstract] [Full Text] [Related]

  • 3. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD.
    Am J Med; 1986 May 23; 80(5B):29-34. PubMed ID: 2872804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):62-7. PubMed ID: 2872809
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of withdrawal of terazosin therapy in patients with hypertension.
    Ruoff G.
    Am J Med; 1986 May 23; 80(5B):35-41. PubMed ID: 2872805
    [Abstract] [Full Text] [Related]

  • 8. Overall safety of terazosin as an antihypertensive agent.
    Sperzel WD, Glassman HN, Jordan DC, Luther RR.
    Am J Med; 1986 May 23; 80(5B):77-81. PubMed ID: 2872812
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
    Cohen A.
    Am J Med; 1986 May 23; 80(5B):86-93. PubMed ID: 2872814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical trials with terazosin. General methods.
    Sperzel WD, Luther RR, Glassman HN.
    Am J Med; 1986 May 23; 80(5B):25-8. PubMed ID: 2872803
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA, Halstenson CE, Matzke GR, Napier JL, Keane WF.
    Pharmacotherapy; 1985 May 23; 5(5):285-9. PubMed ID: 2866492
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
    Achari R, Hosmane B, Linnen P, Cavanaugh J, Baroldi P, Cohen A.
    J Clin Pharmacol; 1998 Jun 23; 38(6):545-53. PubMed ID: 9650545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
    Luther RR, Glassman HN, Estep CB, Schmitz PJ, Horton JK, Jordan DC.
    Am J Hypertens; 1988 Jul 23; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitor.
    Chrysant SG, Bal IS, Johnson B, McPherson MA.
    Clin Cardiol; 1985 Sep 23; 8(9):486-9. PubMed ID: 2864153
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Sep 23; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.